Dr. Julie Louise Gerberding is the CEO of the Foundation for the National Institutes of Health, a non-profit organization that builds public-private research partnerships to support the mission of the NIH. She co-chairs the CSIS Commission on Strengthening America's Health Security and is a member of the Commonwealth Fund Commission on a National Public Health System. Previously, she served as President of the vaccines business and as Executive Vice President and the Chief Patient Officer at Merck & Co., Inc. From 2003-2009, Dr. Gerberding led the U.S. Centers for Disease Control and Prevention (CDC). She serves on the boards of HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University. Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.